What do systematic reviews say?

Xylitol lozenges (4.7 g/day) vs no treatment

• Xylitol‐containing products for preventing dental caries in children and adults 2015 · Cochrane All outcomes

  24 months (48-month follow-up)
  PF -0.10 [-0.59, 0.39]
  1 study · 200 participants
  Very low

Xylitol lozenges (4.7 g/day) vs no treatment

Xylitol lozenges (4.7 g/day) showed no clear difference in number of children with a caries increment compared with no treatment; GRADE not reported.

• Xylitol‐containing products for preventing dental caries in children and adults 2015 · Cochrane All outcomes

  24 months (48-month follow-up)
  RR 1.02 [0.83, 1.26]
  1 study · 200 participants
  GRADE not reported

Acupuncture on the day of ET vs control

Acupuncture on the day of ET showed no clear difference in live birth rate compared with control (low certainty).

• Acupuncture and assisted reproductive technology 2013 · Cochrane Headline outcomes only
  OR 1.22 [0.87, 1.7]
  8 studies · 2505 participants
  Low

Summary of findings: 5 mg/day vs placebo

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

It is very uncertain whether summary of findings: 5 mg/day changes headache ( compared with injection with corticosteroid and anaesthetic (very low certainty).

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  RR 31.003 [1.96, 490.31]
  1 study · 48 participants
  Very low

Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic

It is very uncertain whether summary of findings: 5 mg/day changes injection site pain ( compared with injection with corticosteroid and anaesthetic (very low certainty).

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  RR 0.11 [0.01, 1.96]
  1 study · 48 participants
  Very low

Summary of findings: 5 mg/day vs placebo

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 20 participants
  Low

Summary of findings: 5 mg/day vs placebo

It is very uncertain whether summary of findings: 5 mg/day changes symptom free ( compared with placebo (very low certainty).

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  RR 1.91 [1.04, 3.5]
  1 study · 20 participants
  Very low

Summary of findings: 5 mg/day vs placebo

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs placebo

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings: 5 mg/day vs placebo

The review found no eligible studies for this question.

• Topical glyceryl trinitrate for rotator cuff disease 2009 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Mifepristone (5 mg/day/6 months) vs placebo

Mifepristone (5 mg/day/6 months) showed no clear difference in relief of bleedingdichotomic compared with placebo (low certainty).

• Mifepristone for uterine fibroids 2012 · Cochrane Headline outcomes only
  OR 2.22 [0.54, 9.13]
  1 study · 42 participants
  Low

Mifepristone (5 mg/day/6 months) vs placebo

• Mifepristone for uterine fibroids 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 37 participants
  Low

Mifepristone (5 mg/day/6 months) vs placebo

• Mifepristone for uterine fibroids 2012 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 37 participants
  Low

SCS treatment for 7 or fewer days vs SCS treatment

SCS treatment for 7 or fewer days showed no clear difference in treatment failure Need for additional treatment compared with SCS treatment (moderate certainty).

• Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease 2018 · Cochrane Headline outcomes only
  OR 0.72 [0.36, 1.46]
  4 studies · 457 participants
  Moderate

SCS treatment for 7 or fewer days vs SCS treatment

SCS treatment for 7 or fewer days showed no clear difference in relapse New acute exacerbation or COPD‐related admission compared with SCS treatment (moderate certainty).

• Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease 2018 · Cochrane Headline outcomes only
  OR 1.04 [0.7, 1.56]
  4 studies · 478 participants
  Moderate